Proteomic Characterization of IC Bladder

IC 膀胱的蛋白质组学表征

基本信息

  • 批准号:
    7108521
  • 负责人:
  • 金额:
    $ 29.43万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2003
  • 资助国家:
    美国
  • 起止时间:
    2003-09-30 至 2008-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Interstitial cystitis (IC) is a painful bladder syndrome of unknown etiology, characterized by chronic pelvic pain, urinary frequency and urgency. It affects an estimated 700,000 to one million people in the United States; approximately 90% of the reported sufferers are women. Diagnosis of IC is primarily based on symptoms, as there are no currently available blood or urine tests due to the lack of demonstrated biological markers. The nuclear matrix is the structural scaffolding of the cell nucleus and plays a central role in the regulation of important cellular processes. Specific nuclear matrix proteins (NMPs) have been identified as unique to certain cell types or states. Although the estimated number of different proteins in a cell might outnumber the estimated number of genes in the same cell, proteins are the functional players in cell pathophysiology. Therefore, we propose to use a proteomic approach to identify specific new markers related to chronic cystitis. Several agents, such as Nerve Growth Factor (NGF), nitric oxide (NO) and proinflammatory mediators, have been shown to exert an effect in bladder afferent pathways that could be related to frequent voiding and nociceptive responses in chronic cystitis. Thus, two hypotheses will be tested: 1) Alterations in NMPs are characteristic of the bladder with chronic irritation and can be developed into diagnostic markers and/or treatment targets for painful bladder syndrome such as IC. 2) Functional improvement of chronic cystitis after intervention on NGF, NO, and inflammatory pathways, is associated with changes in NMPs. To address these hypotheses, we propose the following Specific Aims: 1) to perform a comprehensive analysis of the nuclear matrix protein composition of the bladder with chronic irritation in comparison to normal controls to identify specific proteins associated with the disease. 2) to characterize and sequence specific nuclear matrix proteins associated with bladders with chronic irritation and to raise antibodies against these markers and to develop diagnostics tests in this regard. 3) to analyze the effect of several modulators of the bladder afferent pathway, NGF, NO and IPD-1151 T, on specific NMPs associated with the pathogenesis of chronic cystitic bladder. The long-term objectives of this research project are to identify new markers that can be used in sensitive, specific test/screens for IC and may prove of immense value in the accurate diagnosis, and even early prediction, of disease. The results of this research project could also identify new molecular targets of drug therapy for chronic bladder and/or pelvic pain associated with painful bladder syndromes, offering a better outcome for patients with IC.
描述(由申请人提供):间质性膀胱炎(IC)是一种病因不明的膀胱疼痛综合征,其特征是慢性盆腔疼痛、尿频和尿急。据估计,它影响了美国 70 万至 100 万人;大约 90% 的报告患者是女性。 IC 的诊断主要基于症状,由于缺乏已证实的生物标志物,目前尚无可用的血液或尿液检测。核基质是细胞核的结构支架,在重要细胞过程的调节中发挥核心作用。特定的核基质蛋白(NMP)已被确定为某些细胞类型或状态所独有。尽管细胞中不同蛋白质的估计数量可能超过同一细胞中基因的估计数量,但蛋白质是细胞病理生理学中的功能参与者。因此,我们建议使用蛋白质组学方法来鉴定与慢性膀胱炎相关的特定新标记物。神经生长因子 (NGF)、一氧化氮 (NO) 和促炎介质等多种药物已被证明对膀胱传入通路产生影响,这可能与慢性膀胱炎的频繁排尿和伤害性反应有关。因此,将测试两个假设:1)NMP 的改变是慢性刺激膀胱的特征,并且可以开发成膀胱疼痛综合征(例如 IC)的诊断标志物和/或治疗目标。 2)慢性膀胱炎干预NGF、NO和炎症通路后的功能改善与NMPs的变化相关。为了解决这些假设,我们提出以下具体目标:1)与正常对照相比,对慢性刺激膀胱的核基质蛋白组成进行全面分析,以确定与疾病相关的特定蛋白质。 2) 对与慢性刺激膀胱相关的特定核基质蛋白进行表征和测序,并产生针对这些标记物的抗体,并开发这方面的诊断测试。 3) 分析膀胱传入通路的几种调节剂 NGF、NO 和 IPD-1151 T 对与慢性囊炎性膀胱发病机制相关的特定 NMP 的影响。该研究项目的长期目标是确定新的标记物,这些标记物可用于敏感、特异性的 IC 测试/筛查,并可能在疾病的准确诊断甚至早期预测方面具有巨大价值。该研究项目的结果还可以确定药物治疗与膀胱疼痛综合征相关的慢性膀胱和/或盆腔疼痛的新分子靶点,为 IC 患者提供更好的治疗结果。

项目成果

期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Gender-based reciprocal expression of transforming growth factor-beta1 and the inducible nitric oxide synthase in a rat model of cyclophosphamide-induced cystitis.
  • DOI:
    10.1186/1476-9255-6-23
  • 发表时间:
    2009-08-19
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Tyagi P;Tyagi V;Yoshimura N;Witteemer E;Barclay D;Loughran PA;Zamora R;Vodovotz Y
  • 通讯作者:
    Vodovotz Y
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Pradeep Tyagi其他文献

Pradeep Tyagi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Pradeep Tyagi', 18)}}的其他基金

Advancing Bladder Cancer Care by Imaging and Intravesical Immune Checkpoint Blockade
通过影像学和膀胱内免疫检查点阻断推进膀胱癌治疗
  • 批准号:
    10592433
  • 财政年份:
    2022
  • 资助金额:
    $ 29.43万
  • 项目类别:
Advancing Bladder Cancer Care by Imaging and Intravesical Immune Checkpoint Blockade
通过影像学和膀胱内免疫检查点阻断推进膀胱癌治疗
  • 批准号:
    10435605
  • 财政年份:
    2022
  • 资助金额:
    $ 29.43万
  • 项目类别:

相似国自然基金

人和小鼠中新冠病毒RBD的免疫原性表位及其互作抗体的表征和结构组学规律的比较研究
  • 批准号:
    32371262
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
基于吡啶盐的可裂解抗体-药物偶联方法研究
  • 批准号:
    22307081
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
TFAM条件性敲除重塑树突状细胞免疫代谢增强PD-1抗体抗肿瘤作用的机制研究
  • 批准号:
    82303723
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
广谱中和埃博拉病毒的纳米抗体研发以及中和机制研究
  • 批准号:
    82302522
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
新细胞因子FAM19A4联合CTLA-4抗体在肿瘤治疗的功能和机制研究
  • 批准号:
    32370967
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目

相似海外基金

Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
  • 批准号:
    10752129
  • 财政年份:
    2024
  • 资助金额:
    $ 29.43万
  • 项目类别:
Mechanisms of cardiomyocyte dysfunction in pediatric septic shock
小儿感染性休克心肌细胞功能障碍的机制
  • 批准号:
    10580624
  • 财政年份:
    2023
  • 资助金额:
    $ 29.43万
  • 项目类别:
Collaborative cross mice as a new model for diverse human outcomes of St. Louis encephalitis virus disease
协作杂交小鼠作为圣路易斯脑炎病毒病多种人类结果的新模型
  • 批准号:
    10726431
  • 财政年份:
    2023
  • 资助金额:
    $ 29.43万
  • 项目类别:
The role of adrenergic signaling in cancer cachexia-associated cardiac remodeling
肾上腺素能信号在癌症恶病质相关心脏重塑中的作用
  • 批准号:
    10748334
  • 财政年份:
    2023
  • 资助金额:
    $ 29.43万
  • 项目类别:
Multiplex Ultrasound Imaging for the Detection of Head and Neck Lymph Node Micrometastases
用于检测头颈部淋巴结微转移的多重超声成像
  • 批准号:
    10870266
  • 财政年份:
    2023
  • 资助金额:
    $ 29.43万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了